Pfizer Limited (NSE:PFIZER)

Market Cap	228.76B
Revenue (ttm)	23.75B
Net Income (ttm)	8.39B
Shares Out	45.75M
EPS (ttm)	183.47
PE Ratio	27.25
Forward PE	29.14
Dividend	35.00 (0.70%)
Ex-Dividend Date	Jul 9, 2025

Volume	16,564
Average Volume	19,254
Open	5,038.00
Previous Close	5,002.00
Day's Range	4,948.00 - 5,040.00
52-Week Range	3,701.00 - 5,993.00
Beta	0.11
RSI	38.91
Earnings Date	Nov 12, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1950
• Employees: 1,598
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PFIZER

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.